DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Boston Convention and Exhibition Center

2013年6月23日 (日) 午前 8:30 - 2013年6月27日 (木) 午後 12:45

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Narrative Medicine and Pharmacovigilance

Session Chair(s)

Michael A. Ibara, PHARMD

Michael A. Ibara, PHARMD

Chief Data Officer

Elligo Health Research, United States

In recent years, pharmacovigilance has emphasized the collection and submission of tabular data. Using ideas from narrative medicine, we can re-focus on the patient’s story to better understand adverse drug reactions and benefit-risk balance.

Learning Objective : Describe the principles and techniques of narrative medicine;Recognize the importance of narrative information compared to tabular database information;Identify how to obtain higher-quality narrative information from patients provided through both traditional and new media.

Speaker(s)

Jesus  Rivera, MSC

What in the World is Narrative Medicine?

Jesus Rivera, MSC

Bristol-Myers Squibb Company, United States

Senior Learning Manager

Allison  Salke, MBA

Case Study for How the Narrative Improves Clinical Quality

Allison Salke, MBA

Tombolo, Inc., United States

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。